EZH2 and colorectal carcinoma: Our work suggests that AKT-mediated EZH2 phosphorylation reduces the integrity of the PRC2 complex in epithelial CRC cells, attenuating the catalytic activity of PRC2 and enhancing the transcriptional activity of AP1 resulting in increased expression of mesenchymal-related genes.